t(2;3)(p23;q21) TFG/ALK
2001-08-01 Jean-Loup Huret   Affiliation1.Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
Clinics and Pathology
Disease
Epidemiology
only 2 cases to date: a 10 yr old girl and a 19 yr old man.
Clinics
ALK+ ALCL without the t(2;5) (so called cytoplasmic only ALK cases) show clinical features similar to those of classical ALK+ ALCL: young age, male predominance, presentation with advanced disease, systemic symptoms, frequent involvement of extranodal sites, and a good prognosis. Nothing in particular is known concerning t(2;3) cases.
Genes Involved and Proteins
Gene name
ALK (anaplastic lymphoma receptor tyrosine kinase)
Location
2p23.2
Protein description
1620 amino acids; 177 kDa; glycoprotein (200 kDa mature protein) ; membrane associated tyrosine kinase receptor
Gene name
TFG (TRK-fused gene)
Location
3q12.2
Protein description
406 amino acids, 44 kDa; widely expressed
Somatic mutations
apart from the TFG-ALK herein described (see below), TFG is also known to de fused to NTRK1ID: 216> in a subset of
Result of the Chromosomal Anomaly
Description
5 TFG - 3 ALK83 kDa and 96-97 kDa; as the breakpoint in TPM3 was variable , 701 amino acids in the sort er fusion protein, composed of 138 N-term amino acids from TFG, including the cioled-coil oligomerization domain fused to the 562 C-term amino acids from ALK (i.e. the entire cytoplasmic portion of ALK with the tyrosine kinase domain); homodimerization of the fusion protein.
Expression localisation
cytoplasmic localisation (in contrast with the t(2;5)(p23;q35) with NPM1-ALK, which localizes both in the cytoplasm and in the nucleus).
Highly cited references
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 34727172 | 2022 | ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. | 79 |
| 36791109 | 2023 | ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression. | 54 |
| 19888473 | 2009 | Intrinsic structural disorder confers cellular viability on oncogenic fusion proteins. | 51 |
| 11943732 | 2002 | Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity. | 41 |
| 37305584 | 2023 | TFG::ALK fusion in ALK positive large B-cell lymphoma: a case report and review of literature. | 29 |
| 28549458 | 2017 | Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology. | 27 |
| 25148236 | 2014 | Identification of oncogenic mutations and gene fusions in the follicular variant of papillary thyroid carcinoma. | 26 |
| 27874193 | 2017 | ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma. | 24 |
| 33731690 | 2021 | Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition. | 20 |
| 18242762 | 2008 | EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas. | 0 |
| 10556217 | 1999 | TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. | 0 |
| 10994999 | 2000 | Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. | 0 |
| 36748182 | 2023 | Primary inflammatory myofibroblastic tumour of the liver: a clinicopathological and genetic study including a subset with ETV6::NTRK3 fusion. | 0 |
| 15208656 | 2004 | Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells. | 0 |
| 31521978 | 2019 | The clinical responses of TNIP2-ALK fusion variants to crizotinib in ALK-rearranged lung adenocarcinoma. | 0 |
| 14631806 | 2003 | [Anaplastic large-cell lymphoma: review]. | 0 |
| 12112524 | 2002 | Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. | 0 |
| 10807789 | 2000 | Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like). | 0 |
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 10994999 | 2000 | Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. | Drexler HG et al |
| 10556217 | 1999 | TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. | Hernández L et al |
| 11380391 | 2001 | Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma. | Morris SW et al |
| 10381534 | 1999 | t(1;2)(q21;p23) and t(2;3)(p23;q21): two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma. | Rosenwald A et al |
| 11090048 | 2000 | CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. | Stein H et al |
Summary
Fusion gene
TFG/ALK TFG (3q12.2) ALK (2p23.2) M t(2;3)(p23;q12)|TFG/ALK TFG (3q12.2) ALK (2p23.2) TIC

t(2;3)(p23;q21) G- banding - Courtesy Melanie Zenger and Claudia Haferlach.
Citation
Jean-Loup Huret
t(2;3)(p23;q21) TFG/ALK
Atlas Genet Cytogenet Oncol Haematol. 2001-08-01
Online version: http://atlasgeneticsoncology.org/haematological/1217/t(2;3)(p23;q21)-tfg-alk
